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The production of a number of polypeptide mediators or lymphokines under- 
lies  many  of the  differentiated  functions  of T  lymphocytes including  their 
capacity to  influence B  cells,  macrophages,  killer cells, as well as a  variety of 
nonleukocytes.  Lympbokine release begins  when  T  cells  are  stimulated  with 
antigen or mitogen. It quickly ceases when the stimulant is removed. A primary 
control is at tbe level of gene transcription. The stimulation of resting T  cells, 
or  the  restimulation  of isolated  lymphoblasts  and  T  cell  lines,  induces  the 
formation of active lymphokine mRNA (1-5). 
Evidence that  lymphokine mRNA  levels are subject to distinct controls has 
come fi'om studies of the immunosuppressive drug, cyclosporin A (CsA)J  This 
cyclic peptide  blocks  the  production  of several  lymphokines but  has  minimal 
effects on the expression and function of the T  cell's receptor for growth factor 
or 1L-2 (IL-2-R) (1,  3). Several recent studies (1-4) indicate that the mechanism 
of action of CsA is to inhibit the synthesis of lymphokine mRNA that is initiated 
upon addition of mitogens. CsA blocks the production of IL-2 mRNA as assessed 
by nuclear transcription and northern blotting assays, as well as the mRNAs for 
several  other  lymphokines  (IFN-3,,  B  cell-,  and  cytolytic T  cell-stimulating 
factors)  as  shown  with  oocyte  translation  systems  (1-4).  Another  control  of 
lymphokine mRNA appears  to be an endogenous protein,  which in some way 
downregulates the level of IL-2 message (6, 7). 
We have used DNA-RNA blotting to further analyze the control oflymphokine 
mRNA levels. The initial goal was to use a large panel of DNA probes to compare 
lymphokine and nonlymphokine gene expression in terms of kinetics, mitogen 
requirements, and sensitivity to CsA. The probes identified the mRNAs for the 
protooncogenes c-fos, c-myb, and c-myc, the  IL-2-R,  the lymphokines IL-2 and 
IFN, and the 70 kD heat shock protein (HSP). The results show that lymphokine 
and nonlymphokine mRNAs are induced by distinct exogenous stimuli. However, 
IL-2 and IFN mRNAs share with c-myc certain intracellular controls, including 
kinetics of mRNA accumulation and sensitivity to CsA. 
This work was supported by grant CA 30198 from the National Institutes of Health, Bethesda, MD. 
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Materials and  Methods 
Materials.  We purchased leukocyte-rich huffy coats from the New York Blood Center; 
con  A,  (crystallized  three  times)  from  Miles Laboratories  Inc.,  Elkart,  IN;  PMA and 
cycloheximide (CX) from Sigma Chemical Co., St.  Louis, MO; PHA from Gibco, Grand 
Island,  NY;  OKT3  mAb  from  Ortho  Diagnostics,  Raritan,  NJ.  We  were  generously 
supplied with:  CsA and CsH by Drs. J.  F.  Borel and B.  Ryffel,  Sandoz Pharmaceutical, 
Basel, Switzerland; purified rIL-2 (1.2  X  106 U/rag) by Dr.  S.  Rudnick, Biogen, Cam- 
bridge,  MA;  and  several  DNA  probes.  Dr.  P.  Barr  (Chiron  Corp.,  Emeryville,  CA) 
provided oligonucleotide probes to IL-2 and IFN-~,. The IL-2 probe was complementary 
to the 5' region of the IL-2 leader sequence 5'-ATG TAC AGG ATG CAA CTC CTG 
TCT  TGC-3',  and  the  IFN  probe  complementary to  the  3'-untranslated  region  of 
sequence 5'-CTG TAC CCA AAT GGA AAG TAA CTC ATT TGT TAA AAT TATC- 
3'. Alternatively, an IL-2 cDNA, described by Clark et al. (8) was used. cDNA probes for 
c-fos (9), c-myc (10), c-myb (1 I), and IL-2-R (12) were provided by Drs.  H. Hanafusa, The 
Rockefeller University, K.  B.  Marcu,  State  University of New York, Stony Brook, NY, 
Dr.  J.  M.  Bishop,  University  of California,  San  Francisco,  CA,  and  Dr.  W.  Greene, 
National Institutes of Health,  Bethesda,  MD,  respectively. The origin and specificity  of 
the cDNAs for fl-actin and/3~-microglobulin, have been described (13,  14), and a descrip- 
tion of the 70 kD HSP (HSP-70) is in preparation (L. Andrus). 
Cell Cultures.  Blood mononuclear cells were obtained by applying 10 ml of buffy coat 
preparations to  10 ml  Ficoll-Hypaque (Pharmacia Fine Chemicals,  Piscataway,  NJ).  For 
studies of unprimed T  cells, mononuclear populations were cultured at 5 x  106 cells/ml 
in  complete  medium  consisting  of RPMI-1640  (Gibco)  supplemented  with  2%  heat- 
inactivated FCS (Sterile  Systems,  Logan, UT), 20 #g/ml gentamicin sulfate,  5 X 10  -5 M 
2-ME,  and different mitogens: PMA at  10 ng/ml, and  PHA at  1 /~g/ml. For studies of 
lymphoblasts, we cultured cells at 106 cells/ml for 4-5 d in PHA (1 •g/ml).  The cells were 
collected, washed, counted and plated at 2 x  10  ~ cells/ml in  RPMI supplemented with 
2% serum to which different stimulants or inhibitors (CsA; CX) were added (see Results). 
To separate  CD4 and  CD8  subsets,  stimulated  nylon wool-nonadherent T  cells  were 
coated with  OKT4 or OKT8 hybridoma culture supernatant  (American Type Culture 
Collection, Rockville,  MD) and centrifuged onto Petri dishes  coated with anti-mouse Ig 
(Jackson  Immunochemicals, Avondale,  PA).  The  nonadherent cells  were  examined by 
indirect immunofluorescence and found to be depleted of the T  cells that were reactive 
with  the panning mAb, and to be highly (>95%) enriched in the reciprocal T4  + or T8  + 
subset.  In  most experiments,  the  mitogens and  CsA were applied  continuously, but  in 
experiments in which lymphokine release was measured, these agents were applied as a 2- 
h pulse in serum-free medium. Most cells attached to the dishes  in the absence of serum. 
The mitogens and  CsA  were removed by washing and  the attached cells recultured in 
medium (above). 
RNA Blot (Northern) Analysis.  Total cellular RNA was isolated  by a guanidine isothio- 
cyanate method (15) with cesium chloride modification (16), and quantified by absorbance 
at 260 nm. Samples were denatured at 60°C for 10 min in electrophoresis buffer (20 mM 
morholinopropane sulfonic acid, 5 mM sodium acetate,  1 mM EDTA, 3% formaldehyde, 
pH 7.0) containing 50% formamide. RNA was then size-fractionated by electrophoresing 
through  1% agarose gel containing 6%  formaldehyde, then  transferred to gene screen 
filters  (New England Nuclear, Boston, MA).  Filters  were dried, baked at 80°C in vacuo 
for 2  b, treated at 42°C for  t6-20 h  with  prehybridization solution (50%  formamide, 
Denhardt's solution I0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% BSA],  1% SDS,  1 
M  NaCI,  50  mM  Tris  HCI,  pH  7.4,  250  #g/ml  denatured  salmon  sperm  DNA,  and 
hybridized at 42°C for 24 h in the same solution containing [3ZP]cDNA radiolabeled by 
nick translation,  or [3~P]IL-2 and [:~eP]IFN oligonucleotides labeled  with  [32P]ATP and 
polynucleotide kinase (17).  Filters  were washed twice in 2X NaCl/citrate (300 mM NaCI, 
30 mM sodium citrate) for 5 min, twice  in  2X NaC1/citrate with  1%  SDS at 60°C, and 
twice at room temperature for 30 rain.  Filters  were exposed 1-4 d at -70°C to Fuji film 
using intensifying screens. 
Lymphokine Assays.  IL-2 activity in conditioned medium was assayed on mouse lyre- 924  CONTROL  OF  LYMPHOKINE  mRNA  LEVELS 
phoblasts prepared by stimulating spleen cells 3-4 d with Con A (18). Dilutions of medium 
(50 ttl) were cultured with 50 ttl of lymphoblasts (4 X 105 cell/ml). After 18-20 h, the 
cultures were pulsed with 1.7 ttCi [~H]TdR for 4 h. The uptakes we report are from the 
linear  portion  of the  dose-response  curve.  IFN  was  determined by  RIA  (Centocor, 
Malvern, PA). 
In Vitro Nuclear Transcription Assay.  In vitro transcription  was performed according 
to the method of McKnight and Palmiter (19). Briefly, nuclei (10  s) were isolated and used 
immediately to prepare nascent RNA transcripts labeled with [s~P]UTP (3,000 Ci/mM; 
New England Nuclear) for 30 min at 36°C. The nascent RNA transcripts were purified 
by DNase I (RNase free;  50 ttg/ml;  Boehringer  Mannheim,  Houston, TX) treatment, 
proteinase K (25 #g/ml; Boehringer Mannheim) digestion, phenol extraction, and ethanol 
precipitation. The labeled nuclear RNA was then hybridized to excess specific cDNA (10 
ttg) immobilized on nitrocellulose filters. Autoradiographic  exposures were 2-4 d. 
Results 
Stimulus Requirements  for Optimal Release of  L  ymphokines.  Lectin-primed blood 
mononuclear cells proved to be a  useful source of T  cells for studies of mRNA 
levels  in  stimulated  T  cells.  We  first  confirmed  that  the  requirements  for 
lymphokine release from primed cells were similar to those previously reported 
for unprimed populations. 
Human mononuclear cells were enriched in IL-2-responsive T  lymphoblasts 
by culturing for 4-5  d  in PHA. The cells  were washed, restimulated for  16 h 
with a  number of stimuli singly or in concert, and assayed for IFN and  IL-2 
release.  Little IL-2  release occurred after challenge with PMA,  PHA,  or  the 
OKT3  mAb, which reacts with the T3  component of the T  cell receptor for 
antigen/MHC. Low levels of IFN were induced by PMA or PHA. However, the 
mixture of lectin with PMA (Table  I)  or OKT3  with PMA (data not shown), 
were synergistic and induced high levels of lymphokine release. A similar syner- 
gism has been reported in studies of iymphokine production by unprimed guinea 
pig  and  human  T  cells,  and  the  human Jurkat  T  cell  line  (2,  20,  21).  The 
immunosuppressive drug CsA (Table I),  but not the inactive analog CsH (not 
shown), blocked the release of both IL-2 and IFN from T  blasts. 
IL-2  also  induced low  levels of IFN  release  from T  blasts  (Table  I).  This 
response could not be attributed to NK cells, as reported for unprimed popula- 
tions (22,  23),  since IFN production was not altered after treatment with anti- 
NK mAb (Leu-7 and Leu-11) and complement (not shown). 
The effect of exogenous accessory cells was evaluated. Lectin-primed popula- 
tions had  few  monocytes and  dendritic cells,  as  assessed by cytology and by 
surface markers; i.e., there were <1% cells stained with the 3C10 antimonocyte 
mAb, and <0.1% Ia-rich dendritic cells (24). The primed T  cells did not respond 
to lectin (Table I), but addition of plastic adherent cells at a ratio of 1:3 restored 
the lectin response (not shown). With this background information, we proceeded 
to analyze the regulation of lymphokine release at the level of specific mRNAs. 
Kinetics of lnduction of Several mRNAs During Optimal Stimulation of Lymphokine 
Release.  The level of several mRNAs was monitored in primed and unprimed 
T  cells  that  were  stimulated with  lectin and  PMA  (Figs.  1 and  2).  Northern 
blotting showed  that  three  mRNAs:  actin,  /32-microglobulin,  and c-myb, were 
present  in  the  nonstimulated  cells  and  were  not  increased  by  lectin/PMA. 
However, six  other mRNAs were induced, c-fos mRNA  peaked at 0.5  h  and GRANELLI-PIPERNO  ET  AL.  925 
TABLE  I 
Production of lL-2 and IFN-'y upon Restimulation of Human T 
L  ymphoblasts 
IL-2 
Stimulus  (cpm [SH]TdR)  IFN--y (U/ml) 
None  937  0 
PHA (1 #g/ml)  985  26 
PHA +  CsA (1 p.g/ml)  781  0 
PMA (10 ng/ml)  2,428  31 
PMA +  CsA  857  4 
PHA +  PMA  122,889  144 
PHA +  PMA +  CsA  1,307  3 
tiE-2 (300 U/ml)  ND  28 
IL-2 +  CsA  ND  20 
Conditioned medium (15%) was derived from lympboblasts (10  6 cells]ml) 
that had been cultured for 2 h with different stimuli. After 2 h, all stimuli 
except IL-2 were removed, and the incubation was continued for  18 h. 
IL-2 activity was measured in a bioassay using Con A blasts as responders, 
while IFN-~" was measured in an RIA. 
quickly disappeared; IL-2, IFN, and c-myc peaked at 3 h in T  blasts and at 12 h 
in  unprimed T  cells;  and  IL-2-R and  HSP-70  peaked at  20  h  or  later.  In all 
experiments,  HSP-70  mRNA  was  detected in  unstimulated cells,  but  during 
mitogenesis, mRNA levels increased several fold. In comparing the responses of 
T  blasts to unprimed T  cells,  we noted that: (a) the levels of mRNA per cell 
were about fivefo]d higher in the blasts, (b)  the IL-2 and IFN  responses were 
more rapid, and (c)  unprimed T  cells had baseline c-fos mRNA. We elected in 
the next experiments to use lymphoblasts, and we monitored c-fos mRNA levels 
at 30 rain, and the other mRNAs at 4-6 h or at 20 h. 
Stimuli for  Lymphokine  and  Nonlymphokine  mRNas,  and  Effects  of CsA.  The 
highest levels of IL-2 and IFN mRNAs were induced when lectin and PMA were 
added in concert (Fig.  3), just like the release of these lymphokines (Table I). 
Lectin or PMA alone induced little or no response in either IL-2 or IFN mRNA. 
In  contrast,  the  induction of other genes (c-fos, c-myc, IL-2-R)  required  only 
lectin or PMA, and no synergism was observed (Fig. 3). 
The mitogenic OKT3 mAb had no independent effect on any of the mRNAs 
we studied, but was markedly synergistic with PMA in inducing IL-2 and IFN 
mRNAs (Fig.  4).  c-fos,  c-myc, and IL-2-R again responded to PMA alone, and 
there was no synergism with OKT3. 
CsA is known (1-4) to inhibit IL-2 gene transcription, and indeed blocked the 
induction of both  IL-2 and  IFN  mRNAs (Figs.  2-4).  CsH was not inhibitory 
(Fig. 5). CsA also blocked, although not completely, the induction ofc-myc (Figs. 
2-4) as was also noted by Reed et al. (25).  The addition of CsA for 1 h  before 
stimulation  with  lectin  or  PMA  did  not  lead  to  a  complete  block  of c-myc 
induction. In contrast, CsA did not alter the mRNA levels of other nonlympho- 
kine  genes  (c-fos, and  HSP)  in  response  to  either  lectin,  PMA,  OKT3,  or 
combinations thereof (Figs. 2-4). CsA reduced IL-2-R mRNA levels little (Figs. 
2 and 4) or not at all (Fig. 3). 
The northern blotting results were pursued with nuclear transcription assays. 926  CONTROL  OF  LYMPHOK1NE  mRNA  LEVELS 
FIGURE  l.  Time course of mRNA accumulation in T  lymphoblasts. Human T  blasts were 
restimulated with  1 /zg/ml PHA and  10 ng/ml PMA for the indicated times (h). Total RNA 
was isolated, size fractionated (20/~g for probing with IL-2 and IFN, and 10 vg for the other 
genes), and hybridized to szP-labeled probes. Note that all mRNAs except actin are induced, 
although the kinetics for each varies. The c-fos panel has a background band, just above c-fos 
mRNA that was not seen in other blots (see other figures), x, not tested. 
As expected from the prior work of Kronke et al. (26),  the induction of IL-2 
mRNA by PMA and PHA was at the level of transcription, and was CsA sensitive 
(Fig. 6).  Increased transcription of c-myc was also apparent and was blocked by 
CsA  (Fig.  6).  We  conclude that the  induction of lymphokine mRNAs differs 
from nonlymphokine mRNAs in  the requirement for the concerted action of 
PMA and either lectin or OKT3, and in sensitivity to CsA, with the exception 
that c-myc is also CsA sensitive. 
mRNA Levels in T4 and T8 Subsets.  Highly enriched populations of T4+,T8 - 
and T4-,T8  + cells were prepared by panning, and were stimulated with PHA 
and PMA in the presence or absence of CsA. IL-2, IFN, and c-myc mRNAs were 
induced in both subsets, and the induction was CsA sensitive (Fig. 7). 
Effects oflL-2.  IL-2 was also evaluated as a stimulus and was found to induce 
c-myc,  HSP and IL-2-R mRNAs (Fig. 8,  left).  Peak levels were reached in 5 h, GRANELLI-PIPERNO  ET  AL.  927 
FIGURE 2.  Time course of mRNA accumulation in freshly isolated blood mononuclear cells. 
The celts were stimulated with  1 t~g/ml PHA and 10 ng/ml PMA in the presence or absence 
of CsA (1 #g/ml) for the indicated times (h). Total RNA was isolated, size fractionated (70 ug 
for probing with IL-2 and IFN, and 10/~g for the others) and hybridized to 3~P-labeled probes. 
Note  that the  kinetics of expression  of lymphokine and c-myc genes are slower  than  those 
observed in T  blasts (Fig.  1), but again are similar to one another and blocked by CsA. 928  CONTROL  OF  LYMPHOKINE  mRNA  LEVELS 
FIGURE 3.  Expression of mRNAs for lymphokine and nonlymphokine genes after PHA and 
PMA stimulation; effects of CsA.  T  blasts were cultured in the presence of PHA (1  #g/ml), 
PMA (10 ng/ml), or IL-2 (300 U/ml), with or without CsA (1 #g/ml). After 30 min (c-fos) or 
5  h  (all other probes), total RNA was extracted, electrophoresed in  1% agarose gel (20 #g 
RNA for probing with 1L-2  and IFN;  10 #g for the others), and hybridized with s2P-labeled 
probes.  Note  that  IL-2 and  1FN  mRNAs  require the concerted action of PMA and PHA, 
whereas  the  other  mRNAs  respond  to  either  stimulus;  and  CsA  blocks  the  induction  of 
lymphokine and c-myc mRNAs. A, control; B, PHA; C, PHA +  CsA; D, PMA; E, PMA +  CsA; 
F, PHA +  PMA; G, PHA +  PMA +  CsA; H, IL-2; I, IL-2 +  CsA. 
and remained elevated for >24 h  (not shown). IL-2 was a less effective inducer 
than PHA/PMA, but only a fraction of our mononuclear populations (30-50% 
of the cells) stained clearly with the anti-TAC mAb against IL-2-R (not shown). 
IL-2 induced a small IFN mRNA response, and this induction was not blocked 
by CX (Fig. 8,  right).  IL-2 failed to induce its own mRNA (Fig. 8,  right).  CsA 
did not inhibit any of the responses to IL-2 (Fig. 8).  Therefore, IL-2 primarily 
stimulates nonlymphokine mRNAs  in  T  cells,  and  all  the  responses  are  CsA 
insensitive, including that of c-myc. 
Effects  of CX.  Prior studies had indicated that the protein synthesis inhibitor 
CX did not alter lymphokine mRNA levels if applied with the mitogen, but did 
block the downregulation of IL-2 mRNA that occurs at later time points (6,  7). 
We tested whether CsA interfered with the CX effect. CX did not alter mRNA 
levels when given during the first 4 h of mitogen restimulation (Fig. 8, right).  If 
CX was applied at 4-8 h, both IL-2 and c-myc mRNAs were increased relative 
to control, or more precisely, the endogenous downregulation of these mRNAs 
did not occur (Fig. 9).  HSP and IL-2-R mRNAs were not influenced by CX at GRANELLI-PIPERNO ET  AL.  929 
FIGURE 4.  Increase in mRNAs after stimulation with OKT3 mAb and PMA; effects of CsA. 
Human T lymphoblasts  were cultured in the presence of OKT3 (25 ng/ml), PMA (10 ng/ml), 
and CsA (1  #g/ml) added singly or in concert. After 30 rain (c-los) or 5 h (all others), total 
RNA was extracted (20 t~g of RNA for probing with IL-2 and IFN; 10 gg for the others) and 
hybridized with s~P-labeled probes. Note that OKT3 had no effect by itself on mRNA levels, 
and that CsA primary altered the induction of lymphokine and c-myc mRNAs. 
this time (Fig.  9).  If CsA was applied from 4-8 h,  IL-2 and c-myc mRNAs were 
again markedly reduced, but when CX was also present, higher levels of mRNA 
were found (Fig.  9,  right  lane).  Therefore,  there appears  to be a  CX-sensitive 
step that develops several hours after T  cell stimulation and leads to a  lowering 
of IL-2 and c-myc mRNAs. CsA does not seem to inhibit this pathway for increased 
lymphokine mRNA. 
Discussion 
The  availability  of a  large  number  of DNA probes  has  made  it  possible  to 
monitor  the  polyclonal  stimulation  of T  cells  at  the  level  of several  specific 
mRNAs. The  panel  we  used  detected  the  mRNAs for two lymphokines,  IL-2 
and  IFN, which are  major differentiated products of T  cells; three protoonco- 930  CONTROL  OF  LYMPHOKINE  mRNA  LEVELS 
FIGURE 5.  Lack of an effect of the cyclosporin analog CsH. Human T  blasts were cultured 
in the presence of PHA (1 ug/ml) and PMA (I 0 ng/ml), with or without CsA or CsH (1 #g/ml) 
for 5 h. Serial dilutions of total RNA were applied to nitrocellulose using a BioRad dot blot 
apparatus and hybridized with s2p-labeled IL-2 cDNA probe. 
FIGURE 6,  CsA  inhibits c-myc and  IL-2 gene transcription. T  blasts were cultured in  the 
presence of PHA (1 ~g/ml) and PMA (10 ng/ml) with or without CsA (1 ug/ml) for 3 h. Nuclei 
were isolated and nascent RNA chains labeled with [s~p]UTP.  Labeled RNA was hybridized 
with  10 ug of denatured c-myc and IL-2 cDNA immobilized on nitrocellulose. Autoradiograms 
were developed after 2-4 d. 
genes, c-myb, c-myc,  and c-fos, which encode proteins that  localize to the nucleus 
after stimulation of many cell types (10,  32,  34);  HSP-70,  previously detected in 
cells infected with adenovirus or exposed to heat shock (35); and  IL-2-R, which 
is expressed  in  T  cells (26,  36)  and  other  leukocytes.  Three  parameters  were 
monitored: 
Stimuli.  The  expression of lymphokine  mRNAs  required distinct exogenous 
stimuli.  For  IL-2  and  IFN,  optimal  mRNA  induction  required  the  concerted GRANELLI-PIPERNO  ET  AL.  931 
FIGURE 7.  Induction of mRNAs in T cell subsets. Human T blasts (taken after 5 d of culture 
in lectin) were coated with supernatants from the OKT4 or OKT8 hybridoma lines. The cells 
were washed and spun onto Petri dishes coated with affinity-purified Fab2 fragment of goat 
anti-mouse Ig. The nonbound cells were harvested and shown to be highly enriched in T4- 
or T8-bearing cells (>95% pure). The subsets were stimulated with PHA and PMA with or 
without CsA for 5 h. Cytoplasmic RNA was extracted with phenol/chloroform (17),  and  10 
#g  was blotted to  nitrocellulose. The  filters were  hybridized with  *2P-labeled  probes and 
exposed for autoradiography for 3 d. Note that the T  cell subsets show similar induction of 
IL-2, IFN, c-myc, and HSP, and similar sensitivity to CsA. 
action  of PMA  and  either  lectin  or  OKT3  mAb  (Figs.  3-4).  This  finding  on 
primary  T  cells was similar  to that  reported  for lymphokine  mRNA in T  cell 
lines (2), and for lymphokine secretion (20, 21). There was little and sometimes 
no increase in lymphokine mRNA when the T  cells were triggered independently 
by lectin,  PMA,  OKT3,  or IL-2.  In  contrast,  several nonlymphokine  mRNAs: 
IL-2-R, c-myc, and c-fos,  were induced to high  levels by either  lectin,  PMA, or 
IL-2. All these findings seemed to represent direct effects on T  cells, since our 
populations had few accessory cells by the criteria of direct examination and an 
absence  of lectin  responsiveness  (Table  I).  Furthermore,  the  responses  were 
similar in T4 and T8 subsets (Fig. 7). 
The requirement for both OKT3 and PMA during polyclonal activation must 
have a counterpart in the physiologic or antigenic stimulation of T  cells. The T3 
complex is associated with  the T  cell receptor for antigen  and  MHC (37), and 
binding of OKT3 mediates a calcium influx (38, 39). One could reason that this 
influx, and possibly antigen  binding,  do not independently  lead to lymphokine 932  CONTROL  OF  LYMPHOKINE  mRNA  LEVELS 
FIGURE  8.  Effect of rlL-2 on the expression of inducible mRNAs. T  blasts were cultured 6 
h with 300 U/ml rIL-2 or with PHA (1 ttg/ml) and PMA (10 ng/ml) in the presence or absence 
of 1 ~tg/ml CsA. CX was added at 5/zg/ml at the onset of some of the cultures (right).  Note 
that IL-2 induces a significant, but CsA-insensitive increase in c-myc,  HSP, and IL-2-R mRNAs 
(relative to PHA/PMA; left), whereas 1L-2 has little (IFN) or no (IL-2) effect on lymphokine 
mRNAs (right). 
gene expression or to the induction of several genes that are presumably required 
for cell division, i.e., comyc, c-fos, and IL-2-R. These findings are reminiscent of 
the failure of  antigen to independently trigger primary antigen-specific responses 
like the mixed leukocyte reaction and T-dependent antibody formation. Instead, 
primary stimulation requires that antigen be presented in association with den- 
dritic cells,  and  the  response  is  accompanied by the  initiation  of lymphokine 
production (40).  We are therefore testing whether dendritic cells trigger lym- 
phokine mRNAs in antigen-specific systems to a comparable extent to that seen 
with mitogens (OKT3 or PHA) plus PMA. 
Kinetics.  The application of PMA led to the induction of several genes, but 
the kinetics were very different, c-fos appeared early and briefly in stimulated T 
cells, as has been observed in other cell types (32, 33). c-myc was expressed shortly 
after c-fos, and IL-2-R mRNA appeared much later (Figs.  1 and 2). Whereas the 
onset of the PMA response likely involves the activation of protein kinase C, the GRANELLI-PIPERNO  ET  AL.  933 
FIGURE 9.  Effect of CX on  the levels of IL-2 and nonlymphokine mRNA. T  blasts were 
cultured with PHA (1 #g/ml) and PMA (10 ng/ml). CX (10 #g/ml) and/or CsA (1 #g/ml) were 
added at the indicated times. Cells were harvested after 4 or 8 h of culture. Total RNA was 
extracted, separated in agarose gel, and hybridized with s~p-labeled probes. Note that c-myc 
and IL-2 mRNA levels fall between 4 and 8 h (lanes 2 and 3). This decrease is blocked by CX 
even in the presence of CsA (lanes 5 and 7). 
subsequent  steps  leading  to  c-fos,  c-myc,  and  IL-2-R  expression  must  differ  to 
explain such different kinetics. Expression of IL-2 and IFN mRNAs  seems more 
rapid  than  expression of IL-2-R  (Fig.  2).  This  suggests  that  T  cells can  begin 
producing  their  differentiated  products  before  becoming  fully  competent  for 
cell growth.  Therefore,  immunosuppressive  regimes that are directed to the IL- 934  CONTROL  OF  LYMPHOKINE  mRNA  LEVELS 
2-R, such as application of anti-IL-2-R antibodies, may not efficiently ablate T 
cell function, since lymphokines could still be formed. 
CsA.  The profound immunosuppressive effects of CsA on T  cells  are  well 
known, but it is only recently that a selective effect on lymphokine mRNA has 
been stressed (1-4). An exception appears to be the c-myc gene, which is believed 
to encode a  nuclear binding protein,  and which can be induced in many cell 
types (41).  We are  testing whether CsA  will  block c-myc expression  in non-T 
cells, since this could lead to nonspecificity in its clinical action. 
The sensitivity of c-myc to CsA is most useful in analyzing the mechanism of 
action of this drug. It is difficult to argue that CsA blocks signalling at the cell 
surface, since it is apparent that CsA blocks the c-myc response to PMA or lectin, 
but not the response of other genes (c-fos, IL-2-R) to PMA or to lectin. CsA also 
does not block the IL-2-induced increase in c-myc mRNA, or the smaller increase 
in  IFN  mRNA.  The  fact  that  c-myc and  lymphokine mRNAs  also  exhibited 
similar kinetics prompts our working hypothesis that CsA acts on a transcriptional 
control  site that is  shared  by  lymphokine and c-myc genes,  either by  binding 
directly to this region or by inhibiting the function of a  control factor acting 
thereon. 
Summary 
Northern and dot blotting with a panel of DNA probes were used to monitor 
the levels of specific mRNAs in mitogen-stimulated human T cells. The induction 
of IL-2 and IFN mRNAs required the synergistic action of PMA and either PHA 
or OKT3 mAb. In contrast, several nonlymphokine genes, the protooncogenes 
c-fos and c-myc, and the IL-2-R gene, were induced by either PHA or PMA alone. 
PHA increased the background levels of a 70 kD heat shock protein mRNA, but 
did not affect the observed background of c-myb mRNA. For all mRNAs that 
were induced, isolated CD4 and CD8 T cell subsets behaved similarly. Exogenous 
IL-2 had little (IFN) or no (IL-2) effect on lymphokine mRNAs, but significantly 
increased c-myc, IL-2-R and heat shock protein mRNAs. Therefore, the stimuli 
for  lymphokine  mRNAs  differed  from  those  required  for  several  inducible 
nonlymphokine genes. 
IL-2 and IFN mRNAs exhibited some important similarities with c-myc, how- 
ever. The levels of IL-2, IFN, and c-myc mRNA followed similar kinetics, peaking 
at 3 h in restimulated blasts and at 12 h in unstimulated T  cells. The subsequent 
downregulation of iymphokine and c-myc mRN As was retarded by cycloheximide. 
The induction of IL-2, IFN, and c-myc mRNAs was blocked by the immunosup- 
pressive drug CsA, but not by the inactive analog CsH, and this block occurred 
at the level of nuclear transcription. Since the exogenous stimuli for lymphokine 
and c-myc gene expression differ, we suggest that intracellular controls must be 
shared to account for the similarities in  their kinetics of expression and CsA 
sensitivity. 
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